These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33317767)

  • 1. FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge.
    Sousa Pinto G; Hung M; Okoya F; Uzman N
    Res Social Adm Pharm; 2021 Jan; 17(1):1929-1933. PubMed ID: 33317767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring young pharmacists' and pharmaceutical scientists' needs and expectations within an international pharmacy organization: Findings from FIP's needs assessment survey.
    Manikkath J; Matuluko A; Leong A; Ching D; Dewart C; Lim R; Meilianti S; Uzman N
    Res Social Adm Pharm; 2020 Dec; 16(12):1677-1685. PubMed ID: 32169471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How COVID-19 has impacted the role of pharmacists around the world.
    Jordan D; Guiu-Segura JM; Sousa-Pinto G; Wang LN
    Farm Hosp; 2021 Feb; 45(2):89-95. PubMed ID: 33709893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
    Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
    Badreldin HA; Atallah B
    Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists.
    Elnaem MH; Cheema E
    Res Social Adm Pharm; 2021 Jan; 17(1):1938-1941. PubMed ID: 32507575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.
    Cadogan CA; Hughes CM
    Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing FIP's global pharmaceutical education transformation vision in Sub-Saharan African Countries.
    Uzman N; Williams AE; Altiere RJ; Anderson C; Bates I
    Res Social Adm Pharm; 2020 Aug; 16(8):1131-1135. PubMed ID: 31864887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The legal extension of the role of pharmacists in light of the COVID-19 global pandemic.
    Merks P; Jakubowska M; Drelich E; Świeczkowski D; Bogusz J; Bilmin K; Sola KF; May A; Majchrowska A; Koziol M; Pawlikowski J; Jaguszewski M; Vaillancourt R
    Res Social Adm Pharm; 2021 Jan; 17(1):1807-1812. PubMed ID: 32546449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' views on the development of asthma pharmaceutical care model in Indonesia: A needs analysis study.
    Widayati A; Virginia DM; Setiawan CH; Fenty F; Donowati MW; Christasani PD; Hartayu TS; Suhadi R; Saini B; Armour C
    Res Social Adm Pharm; 2018 Dec; 14(12):1172-1179. PubMed ID: 29395903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alaska pharmacists: First responders to the pandemic in the last frontier.
    Paul AK; Bogart T; Schaber AR; Cutchins DC; Robinson RF
    J Am Pharm Assoc (2003); 2021; 61(1):e35-e38. PubMed ID: 33036935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIP Perspectives: Realising global patient safety goals requires an integrated approach with pharmacy at the core.
    Bader L; Kusynová Z; Duggan C
    Res Social Adm Pharm; 2019 Jul; 15(7):815-817. PubMed ID: 30846369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy practice research priorities during the COVID-19 pandemic: Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group.
    Dawoud D; Chen AMH; Rossing CV; Garcia-Cardenas V; Law AV; Aslani P; Bates I; Babar ZU; Desselle S
    Res Social Adm Pharm; 2021 Jan; 17(1):1903-1907. PubMed ID: 32912829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and role of pharmacist in correctional facilities.
    Ta QTH; Nadeem MF; Matti N; Parveen S; Jawad M
    Res Social Adm Pharm; 2021 Jan; 17(1):2042-2043. PubMed ID: 32800459
    [No Abstract]   [Full Text] [Related]  

  • 16. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.
    Mallhi TH; Liaqat A; Abid A; Khan YH; Alotaibi NH; Alzarea AI; Tanveer N; Khan TM
    Front Public Health; 2020; 8():561924. PubMed ID: 33364224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2017 Prescott Lecture: Bridging the intersection between pharmacy, advocacy, and value-based care.
    Wagner A
    J Am Pharm Assoc (2003); 2017; 57(4):439-441. PubMed ID: 28712462
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacists as mid-level practitioners/providers.
    Ross LA
    Ann Pharmacother; 2011 Jun; 45(6):810-2. PubMed ID: 21666080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Daniel K. Inouye College of Pharmacy Scripts: Panic or Panacea, Changing the Pharmacist's Role in Pandemic COVID-19.
    Ma C
    Hawaii J Health Soc Welf; 2020 Jul; 79(7):234-235. PubMed ID: 32666058
    [No Abstract]   [Full Text] [Related]  

  • 20. FIP's Commitment to Action on the WHO Astana Declaration: Transforming pharmacy for better health for all.
    Bader L; Duggan C
    Res Social Adm Pharm; 2020 May; 16(5):724-726. PubMed ID: 31278014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.